The effects of liraglutide on the proliferation and differentiation of mouse pre-osteoblasts MC3T3-E1
Jun Li, Shuang Jin, Juan Zhang, Wei Zhang, Haofeng Zhou, Huijuan Zhang
Abstract
Jun Li, Shuang Jin, Juan Zhang, Wei Zhang, Haofeng Zhou, Huijuan Zhang
Abstract
Objective To investigate the effects of liraglutide on the proliferation and differentiation of mouse pre-osteoblasts MC3T3-E1 exposed to higher glucose concentration. Methods MC3T3-E1 cells were cultured and divided into control group and liraglutide group. In liraglutide group, cells were treated with different liraglutide concentrations (10-9 mol/L, 10-8 mol/L, and 10-7 mol/L, respectively) for 48 hours. Cell proliferation was tested with CCK-8. The mRNA expressions of type Ⅰ collagen (COL-Ⅰ), osteopontin (OPN), and alkaline phosphase (ALP) were detected using semi-quantitative RT-PCR. Results (1)Compared to control group, the proliferation rate of different liraglutide concentration groups (10-9 mol/L, 10-8 mol/L, and 10-7 mol/L) increased significantly (all P<0.05), the proliferation rate was the highest in 10-8mol/L liraglutide group. (2)The expression of COL-Ⅰ, OPN, and ALP mRNA in liraglutide groups were higher than those in control group (all P<0.05). The optimal concentration of liraglutide was 10-8 mol/L. Conclusion Liraglutide within a certain concentration range may improve the proliferation and differentiation of mouse pre-osteoblasts MC3T3-E1. (Chin J Endocrinol Metab, 2016, 32: 232-235) Key words: Glucagon- like peptide-1 analogue; Liraglutide; Osteoblast; Proliferation; Differentiation
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effects of liraglutide on the proliferation and differentiation of mouse pre-osteoblasts MC3T3-E1 exposed to higher glucose concentration. Methods MC3T3-E1 cells were cultured and divided into control group and liraglutide group. In liraglutide group, cells were treated with different liraglutide concentrations (10-9 mol/L, 10-8 mol/L, and 10-7 mol/L, respectively) for 48 hours. Cell proliferation was tested with CCK-8. The mRNA expressions of type Ⅰ collagen (COL-Ⅰ), osteopontin (OPN), and alkaline phosphase (ALP) were detected using semi-quantitative RT-PCR. Results (1)Compared to control group, the proliferation rate of different liraglutide concentration groups (10-9 mol/L, 10-8 mol/L, and 10-7 mol/L) increased significantly (all P<0.05), the proliferation rate was the highest in 10-8mol/L liraglutide group. (2)The expression of COL-Ⅰ, OPN, and ALP mRNA in liraglutide groups were higher than those in control group (all P<0.05). The optimal concentration of liraglutide was 10-8 mol/L. Conclusion Liraglutide within a certain concentration range may improve the proliferation and differentiation of mouse pre-osteoblasts MC3T3-E1. (Chin J Endocrinol Metab, 2016, 32: 232-235) Key words: Glucagon- like peptide-1 analogue; Liraglutide; Osteoblast; Proliferation; Differentiation
Key concepts: Liraglutide, Endocrinology, Internal medicine, Osteoblast, Osteopontin, Chemistry, Cell growth, Mole